# Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients

> **NCT03211286** · PHASE4 · COMPLETED · sponsor: **Alejandro Lizaur-Utrilla, PhD, MD** · enrollment: 129 (actual)

## Conditions studied

- Hip Fractures
- Anemia

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Saline Solution

## Key facts

- **NCT ID:** NCT03211286
- **Lead sponsor:** Alejandro Lizaur-Utrilla, PhD, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-30
- **Primary completion:** 2021-03-02
- **Final completion:** 2022-03-08
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2022-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03211286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03211286, "Effect of Intravenous Tranexamic Acid on Reduction of Blood Losses in Hip Fracture Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03211286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*